NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

newman2021, I believe (like Doc logic) that poly-ICLC gives NWBio a lot of negotiating leverage with Merck, Bristol Myers Squibb, and other BPs who have PD-1 and PDL-1 inhibitors.

Because of the exceptional / miraculous overall survival results, when DCVax is combined with poly-ICLC, big pharma (PD-1 & PDL-1 producers) needs DCVax more than DCVax needs big pharma.

This should help Linda Powers negotiate very favorable partnership agreements with multiple BP partners.